C4 Therapeutics, Inc. - Penyata Pendapatan (TTM)

C4 Therapeutics, Inc.
US ˙ NasdaqGS ˙ US12529R1077

Penyata Pendapatan (TTM)

C4 Therapeutics, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 33 33 34 34 34 46 46 50 48 31 27 16 20 21 20 29 34 36 40 34
Perubahan (%) 0.16 1.84 0.33 0.16 34.78 0.50 8.81 -3.49 -35.65 -12.53 -41.06 26.94 2.00 -3.47 46.63 14.60 5.69 11.80 -13.93
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 74 77 82 87 88 95 100 108 114 118 121 119 118 118 111 105 109 111 115 118
Perubahan (%) 4.65 5.44 6.77 0.42 8.10 6.00 8.01 4.95 3.61 2.41 -1.16 -1.10 -0.22 -5.53 -5.55 3.32 1.96 4.10 2.12
% daripada Hasil 223.35 233.37 241.63 257.13 257.81 206.76 218.07 216.47 235.39 378.96 443.66 744.08 579.72 567.09 554.99 357.49 322.31 310.92 289.51 343.52
Keuntungan Operasi Kasar -41 -44 -48 -53 -54 -49 -54 -58 -65 -87 -93 -103 -98 -97 -91 -76 -75 -75 -75 -83
Perubahan (%) 8.29 8.14 11.31 0.59 -8.82 11.15 7.33 12.19 32.60 7.76 10.45 -5.46 -0.68 -5.97 -17.02 -1.06 0.28 0.45 10.59
% daripada Hasil -123.35 -133.37 -141.63 -157.13 -157.81 -106.76 -118.07 -116.47 -135.39 -278.96 -343.66 -644.08 -479.72 -467.09 -454.99 -257.49 -222.31 -210.92 -189.51 -243.52
SG&A 11 15 20 26 31 33 39 40 41 43 41 41 42 42 41 41 42 42 41 40
Perubahan (%) 36.20 30.04 29.55 21.83 6.57 16.27 3.32 2.82 4.17 -4.38 1.00 2.31 -0.47 -1.56 -1.47 3.03 0.18 -2.27 -2.25
% daripada Hasil 33.68 45.80 58.49 75.52 91.86 72.63 84.03 79.79 85.01 137.60 150.41 257.78 207.77 202.74 206.75 138.92 124.89 118.38 103.48 117.52
R&D 1 1 1 1
Perubahan (%) 0.00 0.00 0.00
% daripada Hasil 2.93 2.88 2.87 2.86
OpEx 85 94 102 114 120 128 139 148 155 161 162 161 160 160 153 146 151 153 156 158
Perubahan (%) 9.93 9.38 11.10 5.24 6.82 8.67 6.71 4.37 3.76 0.60 -0.61 -0.23 -0.29 -4.48 -4.44 3.24 1.46 2.34 0.97
% daripada Hasil 257.04 282.10 302.99 335.51 352.53 279.39 302.10 296.26 320.40 516.56 594.07 1,001.86 787.49 769.84 761.73 496.42 447.20 429.30 392.99 461.03
Pendapatan operasi -52 -60 -69 -80 -86 -82 -93 -98 -106 -130 -134 -145 -140 -139 -133 -116 -117 -117 -117 -124
Perubahan (%) 16.15 13.52 16.40 7.39 -4.25 13.22 5.66 8.38 21.63 3.75 7.58 -3.24 -0.62 -4.64 -12.16 0.37 0.24 -0.53 6.06
% daripada Hasil -157.04 -182.10 -202.99 -235.51 -252.53 -179.39 -202.10 -196.26 -220.40 -416.56 -494.07 -901.86 -687.49 -669.84 -661.73 -396.42 -347.20 -329.30 -292.99 -361.03
Perbelanjaan Faedah -1 -1 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -1 -1 -0 0
Perubahan (%) 78.37 43.45 23.03 -1.06 -0.05 -0.33 0.05 0.70 2.88 3.56 2.88 -16.39 -30.45 -44.14 -78.23 -100.00
% daripada Hasil -2.08 -3.70 -5.22 -6.40 -6.32 -4.68 -4.65 -4.27 -4.46 -7.13 -8.44 -14.73 -9.70 -6.61 -3.83 -0.57 0.00
Pendapatan bersih -55 -66 -75 -87 -90 -84 -95 -99 -107 -128 -131 -140 -135 -132 -126 -108 -105 -105 -103 -112
Perubahan (%) 21.58 13.66 15.63 3.27 -6.82 12.69 5.11 7.32 20.19 2.47 6.48 -3.52 -1.80 -4.84 -14.44 -2.20 -0.17 -1.94 8.04
% daripada Hasil -164.63 -199.83 -223.03 -257.05 -265.03 -183.23 -205.47 -198.48 -220.71 -412.19 -482.83 -872.34 -663.05 -638.34 -629.24 -367.17 -313.35 -295.96 -259.60 -325.88

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista